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Introduction
Juvenile Idiopathic Arthritis (JIA) is term used to classify a
group of heterogeneous pediatric rheumatic diseases.
Many of these conditions remain active until adulthood
and when patients start to be followed by adult Rheuma-
tologists there may arise some classification problems
once AIA (Adult Idiopatic Arthritis) does not exist! Many
published papers regarding the transition of JIA into adult-
hood miss this point.
Objectives
Our aim is to analyze the characteristics of 206 JIA
patients, currently in their adulthood, that have been
followed, in most of their disease, by the same Rheuma-
tologist with a follow-up time superior to 30 years in
some cases.
Methods
This study includes 206 patients currently in adult age
from a sample of 369 JIA patients, continuously followed
by the first author in the Children, Adolescent and
Young Adult Rheumatology Outpatients Clinic at IPR
and Private Practice. All these patients are registered in
REUMA.PT, the National Registry for rheumatic diseases
of the Sociedade Portuguesa de Reumatologia. The 2010
EULAR/ACR Criteria1 for the classification of RA
and the ASAS Criteria for Classification of Axial2 and
Peripheral3 Spondyloarthritis were used.
Results
The group included 126 female and 80 male patients,
with a mean age of 30.0 +/-11.0 years, having mean dis-
ease duration of 21.5 +/-11.3 years. The presentation
forms and definitive diagnosis are listed below. Sixty
three of these patients are in complete and prolonged
off therapy remission. 112 patients were treated with
methotrexate, 42 are or were previously treated with
biological agents, and 33 had been subjected to intra-
articular injections (triamcinolone hexacetonide). Other
aspects concerning therapy, morbidity and mortality
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Table 1
Initial presentation Number of patients Current diagnosis Number of patients
Oligo persistent 58 Still’s Disease 34
Oligo extended 31 Rheumatoid Arthritis 24
Poli FRIgM + 17 Axial Spondylarthritis 14
Poli FRIgM - 23 Perypheral Spondylarthritis 39
Systemic 34 Reactive arthritis 2
Arthritis/Entesitis 30 Psoriatic Arthritis 9
Psoriatic arthritis 7 Inflammatory Bowel Disease Arthropathy 11
Inflammatory bowel disease 6 Oligo/ANA+ with Chronic Uveitis 18
Ocular manifestations Other 16
Uveitis 25 [22 Chronic + 3 Acute] Without definitive diagnosis 39
Fernandes et al. Pediatric Rheumatology 2014, 12(Suppl 1):P193
http://www.ped-rheum.com/content/12/S1/P193
© 2014 Fernandes et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
were also analyzed. All of these patients are registered in
SPR database (REUMA.PT).
Conclusion
It’s clear that JIA is a group of several joint diseases that
start in children and may continue to affect these
patients throughout their adult life. A significative group
of this patients can be classified as juvenile spondyloar-
thritis (75/206 = 36%) This analysis shows that JIAs are
not a benign and self-limiting disease group, being
essential to ensure the proper continuity of rheumatolo-
gic care for these patients in adulthood, preferably using
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